CCL2 and Parkinson disease: Furthermore, reduced plasma levels of CCL2 were identified in patients with mutations in the GBA gene that encodes the enzyme beta-glucocerebrosidase, in comparison with sporadic Parkinson’s disease patients and controls [36].